GlaxoSmithKline Intellectual Property Development Limited
发明人:
申请号：
EP18795802.0
公开号：
EP3692033A1
申请日:
2018.10.04
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Disclosed are compounds having the formula: (I-N) wherein q, r, s, A, B, C, RA1, RA2, RB1, RB2, RC1, RC2, R3, R4, R5, R6, R14, R15, R16, and R17, are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof, along with combinations thereof, all of which are useful in HIV therapies.
